Home › NDC Lookup › RxCUI directory › RxCUI 1115700

Oseltamivir 6 MG/ML Oral Suspension [Tamiflu] — RxCUI 1115700

RxNorm drug concept · Semantic branded drug
RxCUI 1115700 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1115700
Official nameOseltamivir 6 MG/ML Oral Suspension [Tamiflu]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTamiflu 6 MG/ML Oral Suspension; Tamiflu 6 MG in 1 mL Oral Suspension; Tamiflu 6 MG per 1 ML Oral Suspension
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)1,482 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oseltamivir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats influenza A and B when started within 48 hours of the first symptoms. It can also help prevent flu if you have been exposed. It does not replace the yearly flu vaccine.
  • You take it by mouth, as a capsule or liquid. Treatment is usually twice a day for 5 days, and prevention is usually once a day. Food doesn't change how much is absorbed, but follo...
  • Nausea, vomiting and headache are the most common. They are usually mild and often pass in a day or two. If you get a rash, swelling, trouble breathing, or confusion or odd behavio...
  • The flu shot is fine at any time. Avoid the nasal spray vaccine within 2 weeks before or 48 hours after oseltamivir, unless your doctor says otherwise, since it may not work as wel...
📖 Read our full Oseltamivir guide →

🕸️ Concept Web — How Oseltamivir 6 MG/ML Oral Suspension [Tamiflu] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Oseltamivir 6 MG/ML Oral Suspension [Tamiflu] RxCUI 1115700

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oseltamivir 260101
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tamiflu 261657
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oseltamivir Oral Suspension 375196
    • Oseltamivir Oral Liquid Product 1161647
    • Oseltamivir Oral Product 1161648
    • Oseltamivir Oral Suspension [Tamiflu] 581625
    • Tamiflu Oral Liquid Product 1177854
    • Tamiflu Oral Product 1177855
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oseltamivir 6 MG/ML Oral Suspension SCD · 1115698
  • Oseltamivir 6 MG/ML SCDC · 1115697
  • Oseltamivir Oral Suspension SCDF · 375196
  • Oseltamivir Oral Liquid Product SCDG · 1161647
  • Oseltamivir Oral Product SCDG · 1161648

Brand-Name Concepts

  • Oseltamivir 6 MG/ML [Tamiflu] SBDC · 1115699
  • Oseltamivir Oral Suspension [Tamiflu] SBDF · 581625
  • Tamiflu Oral Liquid Product SBDG · 1177854
  • Tamiflu Oral Product SBDG · 1177855
  • Tamiflu BN · 261657

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 1115700 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00004-0800-07 1 BOTTLE, PLASTIC in 1 CARTON (0004-0800-07) / 10 CAPSULE i... Tamiflu Genentech, Inc. 2005-06-17
00004-0800-85 1 BLISTER PACK in 1 CARTON (0004-0800-85) / 10 CAPSULE in 1... Tamiflu Genentech, Inc. 1999-10-27
00004-0802-85 1 BLISTER PACK in 1 CARTON (0004-0802-85) / 10 CAPSULE in 1... Tamiflu Genentech, Inc. 1999-10-27
00004-0822-05 1 BOTTLE, GLASS in 1 CARTON (0004-0822-05) / 60 mL in 1 BOT... Tamiflu Genentech, Inc. 2011-03-21
Observed labelers: Genentech, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.